Clinical Pharmacology, Organic Chemistry and Pharmaceuticals

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Pharmacology

Organic Chemistry

Pharmaceuticals

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

JULY 4, 2023

Author bios: Dr Petra Dieterich Petra has 30 years’ experience of drug development in the Pharmaceutical industry with a focus on supporting CMC activities. Working in the CRO and CDMO environment she has led projects for customers across the globe, helping them to achieve their goals in clinical trials and low volume commercial manufacture.

Small Molecule

Small Molecule Drugs Clinical Pharmacology Trials

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

NOVEMBER 8, 2023

Adams, on a first-in-human study of ELU001, a targeted c’dot drug conjugate, in subjects with folate receptor α (frα) overexpressing solid tumours, and Groothuis on the non-clinical pharmacology of the MET-targeting ADC BYON3521.

Engineering

Engineering Protein Expression Therapies Science

Drug Discovery Digest

Antibody Drug Conjugates: windows of opportunity

What to expect from PEGS Europe 2023: Day 1

Stay Connected